Evidence map›Paper›PMID 19567511›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2009

Responses to online GSTM1 genetic test results among smokers related to patients with lung cancer: a pilot study.

Saskia C Sanderson, Suzanne C O'Neill, Della Brown White, Gerold Bepler, Lori Bastian, Isaac M Lipkus, Colleen M McBride

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01176383 (A Protocol for an Randomised Controlled Trial of Smoking Cessation Success Rate With or Without a Genetic Test, "Respiragene", to Assess Lung Cancer Risk - an Exploratory Study), which is not on this map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01176383 nacompletednot on this mapstarted 2011, after this paper: background citation

A Protocol for an Randomised Controlled Trial of Smoking Cessation Success Rate With or Without a Genetic Test, "Respiragene", to Assess Lung Cancer Risk - an Exploratory Study

TypeinterventionalSponsorSussex NHS Research ConsortiumRan2011 to 2013Enrolled67ConditionsSmoking CessationArmsRespiragene test and risk score
3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Behavioral impact of return of genetic test results for complex disease: Systematic review and meta-analysis.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2018
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. A mechanistic test of nicotine replacement therapy sampling for smoking cessation induction.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2015
    Trial
  8. Trial
  9. Trial
  10. Trial
  11. Brief, instructional smokeless tobacco use among cigarette smokers who do not intend to quit: a pilot randomized clinical trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2014
    Trial
  12. Trial
  13. Evaluation of a brief web-based genetic feedback intervention for reducing alcohol-related health risks associated with ALDH2.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2010
    Trial
  14. Article
  15. How Do Patients Respond to Genetic Testing for Age-related Macular Degeneration?Optometry and vision science : official publication of the American Academy of Optometry · 2018
    Article
  16. Marshaling the Translational Potential ofCancer prevention research (Philadelphia, Pa.) · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Saskia C SandersonDepartment of Genetics and Genomic Sciences, Mount Sinai School of Medicine, Icahn Medical Institute, New York, NY 10029, USA. saskia.sanderson@mssm.edu
Suzanne C O'Neill
Della Brown White
Gerold Bepler
Lori Bastian
Isaac M Lipkus
Colleen M McBride
National Human Genome Research Institute · USDuke Medical Center · USGeorgetown University · USIcahn School of Medicine at Mount Sinai · USMaineGeneral Medical Center · USUniversity of South Florida · US

Funding

Family Risk and Lung Cancer StudyZ01HG200315 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI MC BRIDE, COLLEEN M · 2004 to 2008
$2.1M
Intramural NIH HHS Z01 HG200315NCI NIH HHS U01 CA09622
6 · The paper itself

Abstract

Providing smokers with personal genetic test results indicating increased lung cancer risk may increase uptake of effective smoking cessation services. Using the internet may increase reach and enable real-time assessment of how people process genetic risk information away from the clinic setting. We therefore explored smokers' responses to Web-delivered GSTM1 genetic test results indicating higher or lower lung cancer risk. Participants were smokers (n = 44) biologically related to patients with newly diagnosed lung cancer. Measures were assessed at baseline, before and immediately after receipt of online genetic test results, and at 6-month follow-up. Outcomes included accurate comprehension of results, regret about being tested, cessation-related cognitions (e.g., perceived response efficacy), and uptake of free smoking cessation services (nicotine replacement therapy, printed self-help materials, telephone counseling sessions). Twenty-two "relative smokers" received a GSTM1-missing (higher risk) and 22 a GSTM1-present (lower risk) result. All relative smokers with GSTM1-missing results and 55% of those with GSTM1-present results accurately interpreted their results. No relative smokers regretted having taken the test. Relative smokers receiving GSTM1-missing results reported lower confidence that quitting could reduce lung cancer risk (perceived response efficacy) than those receiving GSTM1-present results. There were no other significant between-group differences. Uptake of smoking cessation services was high (e.g., 91% nicotine replacement therapy uptake). Genetic test results may not influence uptake of free smoking cessation services because of ceiling effects. Further research is needed to determine the risks and benefits of Web-based disclosure of genetic test results.

Indexed as

Genetic Predisposition to DiseaseInternetAdultCarcinoma, Non-Small-Cell LungCounselingFemaleGenetic TestingGenotypeGlutathione TransferaseHealth BehaviorHumansLung NeoplasmsMaleMiddle AgedPilot ProjectsRisk FactorsGlutathione Transferase

Identifiers

PMID19567511
PMCPMC3417294
OpenAlexW1992601792

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.